Weight management (GLP-1 agonists) and pharmacogenetics
Also known as: GLP-1 agonists, Incretin agonists, Weight loss medications
Which GLP-1 medication will sit better with me?
Depending on your genotype, these 3 medications split into up to 2 groups, from take-as-directed through to worth avoiding. Gene2Rx Pro reads GIPR and GLP1R from your own report and tells you which is which.
Why pharmacogenetics matter for weight management (glp-1 agonists)
GLP-1 receptor agonists (semaglutide, tirzepatide, retatrutide) are the dominant new drug class for weight management and type 2 diabetes. They all work the same way: activating incretin receptors slows gastric emptying, increases satiety, and improves insulin response. Two SNPs are robustly associated with how people respond, though they account for only a small share of the overall variation, most of which is non-genetic. GLP1R rs10305420 affects every drug in the class. GIPR rs1800437 only matters for drugs that also activate GIP, which is tirzepatide and retatrutide.[1]
The most actionable pharmacogenetic signal in this class is the GIPR Gln354 variant. If a patient stops tirzepatide because of nausea and carries that variant, switching to semaglutide is a logical next step. Semaglutide doesn't bind GIPR, so the variant doesn't apply.
For a deeper walk-through of the GLP1R variant associated with weight loss, and the GIPR variant associated with nausea and vomiting risk on tirzepatide, see our GLP-1 genetics guide.
Key genes in this class
- GLP1RGlucagon-Like Peptide-1 ReceptorGLP1R is the cell-surface receptor that GLP-1 drugs like semaglutide and tirzepatide bind to. A common variant (rs10305420, Pro7Leu) changes how efficiently the receptor gets made and shipped to the …
- GIPRGastric Inhibitory Polypeptide ReceptorGIPR is the receptor for GIP, the second incretin hormone. It is the target of the GIP arm of tirzepatide and retatrutide. The Glu354Gln variant (rs1800437) lowers GIPR function, and …
Medications in this class covered by Gene2Rx
Explore each medication's genetic findings, supporting sources, and report information.
Brand products in the GLP-1 weight management class
Combined products and brand names for the medications above. Each links to a pharmacogenetic breakdown.
References
- PharmGKB / Stanford University. PharmGKB: The Pharmacogenomics Knowledge Base. pharmgkb.org
Which glp-1 weight management is right for your genetics?
Informational only, not medical advice. Pharmacogenetic guidelines describe population-level patterns that inform prescribing decisions. Never start, stop, or change a medication without talking to your prescribing clinician.